Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma
The prognostic impact of pre-operative p53 and PR expression in patients with grade 2 endometrioid endometrial carcinoma supports a modified binary grading system in which grade 2 patients should be pre-operatively classified as low- or high-grade depending on p53 and PR expression.
Authors
- Dennis van Hamont (ORCID: https://orcid.org/0000-0001-5928-3269)
- Stephanie Vrede
- Koen Van de Vijver (ORCID: https://orcid.org/0000-0002-2026-9790)
- Jitka Hausnerová (ORCID: https://orcid.org/0000-0002-0522-1916)
- A.A.M. van der Wurff
- L Alcala
- Frédéric Amant (ORCID: https://orcid.org/0000-0002-5452-4905)
- Carolien M. Bronkhorst
- Nicole C.M. Visser (ORCID: https://orcid.org/0000-0003-3919-3922)
- Camilla Krakstad (ORCID: https://orcid.org/0000-0002-0174-8139)
- Antonio Gil‐Moreno (ORCID: https://orcid.org/0000-0003-1106-5590)
- Jone Trovik
- Ingfrid S. Haldorsen (ORCID: https://orcid.org/0000-0001-9313-7564)
- Loes F. S. Kooreman (ORCID: https://orcid.org/0000-0001-8226-8665)
- Vít Weinberger (ORCID: https://orcid.org/0000-0003-4858-1951)
- Heidi V.N. Küsters‐Vandevelde (ORCID: https://orcid.org/0000-0002-1012-941X)
- Markéta Bednaříková (ORCID: https://orcid.org/0000-0003-3189-7028)
- Marieke Smink
- Gemma Mancebo (ORCID: https://orcid.org/0000-0001-5859-7936)
- Johanna M.A. Pijnenborg
- Brenda Pijlman (ORCID: https://orcid.org/0000-0003-1449-3726)
- Johan Bulten (ORCID: https://orcid.org/0000-0002-8168-6045)
- Petra Bretová (ORCID: https://orcid.org/0000-0003-1082-433X)
- Xavier Matías‐Guiu (ORCID: https://orcid.org/0000-0002-7201-6605)
- Henrica M.J. Werner (ORCID: https://orcid.org/0000-0001-5186-8369)
- Jasmin Asberger (ORCID: https://orcid.org/0000-0003-2226-769X)
- Marı́a Santacana (ORCID: https://orcid.org/0000-0003-1975-2598)
- Viola M.J. Verhoef
- Martin Koskas (ORCID: https://orcid.org/0000-0003-3872-2810)
- Jutta Huvila
- Puk Meijs-Hermanns
- Huy Ngo (ORCID: https://orcid.org/0000-0001-6206-1624)
- Dorry Boll (ORCID: https://orcid.org/0000-0002-9673-7845)
Institutions
- Hebron University (PS)
- Universitat Autònoma de Barcelona (ES)
- Radboud University Nijmegen (NL)
- University of Turku (FI)
- Turku University of Applied Sciences (FI)
- Masaryk University (CZ)
- Maastricht University Medical Centre (NL)
- Haukeland University Hospital (NO)
- Ghent University Hospital (BE)
- Catharina Ziekenhuis (NL)
- University Medical Center Freiburg (DE)
- Hospital Universitari Arnau de Vilanova (ES)
- Radboud University Medical Center (NL)
- Maastricht University (NL)
- Assistance Publique – Hôpitaux de Paris (FR)
- Vall d'Hebron Institut de Recerca (ES)
- Eurofins (Netherlands) (NL)
- Amphia Ziekenhuis (NL)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Elkerliek Ziekenhuis (NL)
- Máxima Medisch Centrum (NL)
- Hospital Del Mar (ES)
- Hôpital Bichat-Claude-Bernard (FR)
- Elisabeth-TweeSteden Ziekenhuis (NL)
- Jeroen Bosch Ziekenhuis (NL)
- KU Leuven (BE)
Publication Details
- Journal
- International Journal of Gynecological Cancer
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.ijgc.2025.101682
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00